Cite
MLA Citation
Julie Bauman et al.. “798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A846. http://access.bl.uk/ark:/81055/vdc_100144727381.0x000006